5.5 years after first Roundup lawsuits were filed, pharmaceutical company Bayer which purchased Monsanto in 2018 is still in the process of resolving claims. Most recently in Ninth Circuit to request preliminary approval of a settlement deal with a total value of $2 billion.
To print this article, all you need is to be registered or login on Mondaq.com.
CASE LAW DEVELOPMENTS
A Pharmaceutical Conflict over an ICC Award Is Building
Momentum
The Taiwanese company PharmaEssentia is trying to challenge an
ICC award issued in a dispute with its Austrian counterparty. The
dispute arose over a license agreement for the development and
commercialization of a leukemia drug.
In October 2020, the ICC tribunal ruled in favor of the Austrian
company AOP Orphan Pharmaceuticals, awarding it EUR 2 billion. The
dispute resulted from PharmaEssentia s attempt to terminate a
license agreement, under which it undertook to provide to AOP